

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
You can purchase shares of Codexis (NASDAQ:CDXS) through any online brokerage.
Other companies in Codexis’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Codexis has a consensus price target of $9.50.
The stock price for Codexis (NASDAQ: CDXS) is $1.31 last updated October 23, 2026 at 7:29 PM EDT.
There are no upcoming dividends for Codexis.
Codexis does not have any upcoming earnings scheduled.
There is no upcoming split for Codexis.
Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small...